Epivir (lamivudine) Tablets and Oral Solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 WARNINGS AND PRECAUTIONS Lower Virologic Suppression Rates and Increased Risk of Viral Resistance with Oral Solution ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts